Eu Jeen Yang

Dr. Eu Jeen Yang

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
EYEu Jeen Yang
Eu Jeen Yang
HHHyeong Seok Ha
Hyeong Seok Ha
YKYoung Hwa Kong
Young Hwa Kong
SKSun Jun Kim
Sun Jun Kim
Yang EJ, et al. Korean J Pediatr. 2015 Apr;58(4):136-141. http://dx.doi.org/10.3345/kjp.2015.58.4.136

1 January 2017 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
SHSeung-A Han
Seung-A Han
EYEu Jeen Yang
Eu Jeen Yang
MSMi-Kyoung Song
Mi-Kyoung Song
SKSun Jun Kim
Sun Jun Kim
The purpose of this study was to investigate the effects of lamotrigine for the treatment of attention-deficit hyperactivity disorder (ADHD) symptoms in children with epilepsy. Pediatric patients newly diagnosed with epilepsy (n=90 [61 boys and 29 girls]; mean age, 9.1±3.4 years) were enrolled. All patients were evaluated with the Korean ADHD rating scale (K-ARS)-IV before treatment with lamotrigine and after doses had been administered. The mean interval of ADHD testing was approximately 12.3 months. The initial dosage of lamotrigine was 1 mg/kg/day (maximum 25 mg/day for the first 2 weeks), and increased by 1 mg/kg every 2 weeks until titrated up to 7 mg/kg/day (or maximum 200 mg/day). The mean ADHD test score of the 90 subjects was 17.0±1.8 at baseline. It was slightly reduced to 15.6±1.7 after lamotrigine monotherapy (P >0.01). Prior to treatment, a total of 31 patients (34.4%) met the diagnostic criteria for ADHD according to Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision, Of these 31 patients, 27 (87.1%) had significantly improved ADHD scores with lamotrigine monotherapy (28.0±1.6 reduced to 18.1±2.6, P<0.001). Among these 27 patients, 25 (92.6%) showed normalized electroencephalogram (EEG) and 26 (96.3%) achieved total freedom from seizures within 12 months of the initiation of lamotrigine monotherapy. The results from our study show that lamotrigine had a positive effect in pediatric epilepsy patients by reducing ADHD symptoms, preventing seizures, and normalizing EEG. However, further research is required to determine whether lamotrigine is efficacious against ADHD symptoms independent of its effects on epileptic seizures.

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YSYe Jee Shim
Ye Jee Shim
HJHye Lim Jung
Hye Lim Jung
HSHee Young Shin
Hee Young Shin
HKHyoung Jin Kang
Hyoung Jin Kang
JCJung Yoon Choi
Jung Yoon Choi
THThe Red Blood Cell Disorder Working Party Of The Korean Society Of Hematology
The Red Blood Cell Disorder Working Party Of The Korean Society Of Hematology
Shim YJ, et al. J Korean Med Sci. 2020 Jul;35(33):e279. https://doi.org/10.3346/jkms.2020.35.e279

1 January 2015 in Korean Journal of Family Medicine
Verified
Journal Article
Open access
PDF file
MKMinsun Kim
Minsun Kim
EYEu Jeen Yang
Eu Jeen Yang
DCDong Hyu Cho
Dong Hyu Cho
PHPyung Han Hwang
Pyung Han Hwang
DLDae-Yeol Lee
Dae-Yeol Lee
Kim MS, et al. Korean J Fam Med. 2015 May;36(3):150-153. http://dx.doi.org/10.4082/kjfm.2015.36.3.150

1 November 2017 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
KPKyung Mi Park
Kyung Mi Park
EYEu Jeen Yang
Eu Jeen Yang
YLYoung Tak Lim
Young Tak Lim
Intravenous immunoglobulin (IVIG) is a widely used agent as the first choice of treatment of immune thrombocytopenic purpura (ITP). IVIG has several side effects, but it is a relatively safe treatment. Life-threatening thrombosis has been reported in adults and rarely in children. We report a case of a 14-year-old boy with dural venous sinus thrombosis and pulmonary embolism after treatment with IVIG for ITP. The patient was treated with low–molecular-weight heparin followed by warfarin and the symptoms were recovered. If a patient with ITP shows mental change or respiratory difficulty, we should consider thrombosis as well as hemorrhage.

6 September 2018 in Laboratory Medicine
Verified
Journal Article
Closed access
KSKyung-Hwa Shin
Kyung-Hwa Shin
HLHyun-Ji Lee
Hyun-Ji Lee
DSDuyeal Song
Duyeal Song
SLSun-Min Lee
Sun-Min Lee
IKIn Suk Kim
In Suk Kim
KPKyung-Hee Park
Kyung-Hee Park
Background Hyperbilirubinemia, which is a sign of hemolytic disease of the newborn (HDN), can irreversibly damage the central nervous system. Objectives To determine the etiology of HDN in affected patients and characterize the changing pattern of bilirubin using direct antiglobulin testing (DAT). Methods We collected clinical data from newborns who underwent perinatal DAT and from their mothers, between August 2008 and July 2017. Results Among 303 neonates, 37 (12.2%) showed positive DAT results. The positive predictive values (PPVs) and negative predictive values (NPVs) based on DAT results were 75.7% and 28.9%, respectively, for starting phototherapy. Bilirubin levels increased more rapidly in the DAT-positive group, compared with the DAT-negative group. The initial bilirubin level differed significantly according to the etiology of hyperbilirubinemia. Further, neonates with anti-D showed higher delta bilirubin per day than neonates with other antibodies. Conclusion Our results may help to determine the measurement period for bilirubin according to DAT results and etiology.